Tecovirimat,(ST-246, SIgA-246) is an inhibitor of p37 envelope proteins used to treat smallpox infection. Tecovirimat is an antiviral drug that is active against orthopoxviruses such as smallpox and is currently undergoing clinical trials. Its role is to prevent disease by blocking the cellular transmission of the virus.

1162664-19-8

C19H17F3N2O4

394.34

ST 246;SIGA-246;ST246;ST-246;SIGA246;SIGA 246;Tecovirimat hydrate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years